Refers to article:
Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden
Accepted 6 September 2011
April 2012 (Vol. 61, Issue 4, pages 690 - 700)
Refers to article:
Re: Mieke Van Hemelrijck, Hans Garmo, Lars Holmberg, et al. Multiple Events of Fractures and Cardiovascular and Thromboembolic Disease Following Prostate Cancer Diagnosis: Results From the Population-Based PCBaSe Sweden. Eur Urol 2012;61:690–700
April 2012 (Vol. 61, Issue 4, page e27)
We would like to thank Cai et al. for their interest in our recent study  on the frequency of multiple events (eg, fractures, stroke, heart disease, and thromboembolic disease) following prostate cancer (PCa) diagnosis. The authors are right in highlighting that it is of interest to study erectile dysfunction (ED) in relation to cardiovascular disease and PCa.
We have recently created PCBaSe 2.0, with further data on PCa cases in the National Prostate Cancer Register of Sweden and a selection of two control series of men free of PCa at the date of diagnosis of the index case and matched on age and county of residence. PCBaSe 2.0 includes information from the Prescribed Drug Register and Swedeheart , available from 2005. This will make it possible to study medical treatment for ED and heart disease among men with PCa years before the date of diagnosis as well as among their age-matched controls.
Conflicts of interest
The authors have nothing to disclose.
-  M. Van Hemelrijck, H. Garmo, L. Holmberg, P. Stattin, J. Adolfsson. Multiple events of fractures and cardiovascular and thromboembolic disease following prostate cancer diagnosis: results from the population-based PCBaSe Sweden. Eur Urol. 2012;61:690-700 Abstract, Full-text, PDF, Crossref.
-  The register of information and knowledge about Swedish heart intensive care admissions, 2008. RIKS-HIA International Web site. http://www.ucr.uu.se/rikshiaint/. Accessed July 7, 2011.
a King's College London, School of Medicine, Division of Cancer Studies, Cancer Epidemiology Group, London, UK
b Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden
c Department of Surgery, Urology Service, Memorial Sloan-Kettering Cancer Center, New York, USA
d Oncological Center, CLINTEC Department, Karolinska Institutet, Stockholm, Sweden
Corresponding author. King's College London, School of Medicine, Division of Cancer Studies, Cancer Epidemiology Group, Research Oncology, 3rd Floor, Bermondsey Wing, Guy's Hospital, London SE1 9RT, UK Tel. +44(0)20 7188 7904.
© 2011 European Association of Urology, Published by Elsevier B.V.